drugset / Trial / NCT04080323
Single-dose Vaginal Dinoprostone and Hysterectomy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
In this study, we will assess the efficacy of dinoprostone in minimizing blood loss during hysterectomy when used as a single preoperative dose via the vaginal route. The reduction of blood flow may be due to the combined effect of myometrial contraction and vasoconstrictive effect
Timeline
- Start
- 2019-09-25
- Primary completion
- 2020-05-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dinoprostone | Other / unclassified | 3 mg | Other |
Indications
No indication recorded.